Candida albicansandCandida kruseiDifferentially Induce Human Blood Mononuclear Cell Interleukin-12 and Gamma Interferon Production
- 1 May 2000
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (5) , 2464-2469
- https://doi.org/10.1128/iai.68.5.2464-2469.2000
Abstract
Protection againstCandidainfection involves both innate and acquired immune responses, and cytokines produced by monocytes during the innate response may modify the acquired immune response by T cells. We hypothesized thatCandidaspecies which differ in pathogenicity can differentially induce production of immunoregulatory cytokines by human monocytes, which in turn modify T cells for immune responses toCandida. To test this hypothesis, we examined the effects ofCandida albicansandCandida kruseion immunoregulatory cytokine production by human monocytes and gamma interferon (IFN-γ) production by peripheral blood mononuclear cells (PBMC). Purified monocytes were incubated with live or heat-killed strains ofC. albicansandC. kruseiat the optimalCandida/monocyte ratio of 0.5. Cytokines in the supernatants were measured by enzyme-linked immunosorbent assay. Our data demonstrated that liveC. albicansandC. kruseisignificantly induced interleukin-10 (IL-10), monocyte chemotactic factor 1, IL-1β, and tumor necrosis factor alpha production by monocytes relative to unstimulated monocytes. In contrast, unlikeC. krusei, pathogenic live strains ofC. albicansinduced no or only a minimal level of IL-12. The expression of IL-12 p40 mRNA levels by reverse transcription-PCR corroborated the IL-12 protein (p70) findings. In human PBMC, human blood monocytes were the major source of both IL-10 and IL-12 production in response toC. albicansandC. krusei. Upon activation of T cells in the presence ofCandida-modified monocytes and antigen-presenting cells, IL-12 production by PBMC treated withCandidaorganisms correlated strongly with the level of IFN-γ production by T cells. These results indicate that the virulence ofC. albicansmay be related to its ability to induce the monocytic type II cytokine IL-10, with a selective inhibition of IL-12 production, which may be responsible for the observed lack of T-cell IFN-γ and may restrain an effective type I immune response toCandida.Keywords
This publication has 41 references indexed in Scilit:
- EFFECTS OF A CORTICOSTEROID, BUDESONIDE, ON PRODUCTION OF BIOACTIVE IL-12 BY HUMAN MONOCYTESCytokine, 1998
- Neutrophils and the adaptive immune response to Candida albicansResearch in Immunology, 1996
- Interleukin‐4 and ‐10 exacerbate candidiasis in miceEuropean Journal of Immunology, 1995
- Importance of Candida Species Other than C. albicans as Pathogens in Oncology PatientsClinical Infectious Diseases, 1995
- The Role Of Phagocytic Cells In Resistance To Disseminated Candidiasis In Granulocytopenic MiceThe Journal of Infectious Diseases, 1994
- Interleukin‐4 and interleukin‐10 inhibit nitric oxide‐dependent macrophage killing of Candida albicansEuropean Journal of Immunology, 1993
- Interleukin-10Annual Review of Immunology, 1993
- Interferon-gamma activates the oxidative killing of Candida albicans by human granulocytesClinical and Experimental Immunology, 1993
- Neutrophil Oxidative Burst in Response to Blastoconidia and Pseudohyphae of Candida albicans: Augmentation by Granulocyte Colony-Stimulating Factor and Interferon-The Journal of Infectious Diseases, 1992
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991